OTC presentations of ranitidine have been pulled from shelves in Denmark, Finland and Norway after the European Medicines Agency launched a review into the drug over safety fears.
Denmark, Finland and Norway are the latest European countries to withdraw from sale certain OTC ranitidine-based drugs following a worldwide alert over the ingredient’s safety.
National regulators in the three Nordic countries have withdrawn from sale all OTC and prescription versions of ranitidine in response...
Create an account to read this article
Already a subscriber?
Established by Max Gowland in 2013, Prime Fifty was founded to address the specific nutritional needs of the over 50s.
Centrum Vitamin D Boost combines a wide range of daily vitamins with a 30-microgram dose of vitamin D, delivering six times more of the micronutrient than the firm’s Centrum Advance.
Concerns raised by two recent studies prompt UK researchers to argue for greater regulation with regards to direct-to-consumer test kits.
AESGP has formally submitted a request to the General Court of the European Union to intervene in the European Federation of Pharmaceutical Industries and Association’s legal action against the revised EU Urban Wastewater Directive.
HBW Insight speaks to Prime Fifty founder and managing director Max Gowland about the science behind healthy aging and the opportunity for the consumer health industry.
What's going on with the EU Green Claims Directive? HBW Insight speaks to the European Commission, Parliament and Council to find out why trilogue negotiations seem to have stalled.
Germany’s Expert Committee for Prescription supports the Rx-to-OTC switches of melatonin and buccal acyclovir but rejects rupatadine.
